Back to search
Neurodegenerative Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neurodegenerative Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neurodegenerative Disorders trials you may qualify forCaring for people with pancreatic cancer requires good coordination between hospital care and care at home, with different healthcare professionals working clos…
Active-NBS is a study to evaluate the muscle development of patients with spinal muscular atrophy (SMA) who are diagnosed at birth. Medicines have become avail…
The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the s…
The purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.
This is a phase 1/2 clinical study to evaluate the safety, tolerability, feasibility, and preliminary efficacy of NouvNeu001 in patients with advanced Parkinson…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
This study's main hypothesis is that a delivering a tailored lighting intervention (TLI) will provide a successful means for promoting circadian entrainment and…
Alzheimer's disease and related dementias (ADRD) are leading causes of disability and often result in communication deficits of the person with dementia (PWD) t…
Spinal muscular atrophy is a genetic disorder characterized by progressive muscle weakness, severely impacting patients' motor abilities. Several disease modify…